Lexeo Therapeutics, Inc. Common Stock
XNAS:LXEO
10.75
$12.82 - 241.00
$10.07 - 30.00
$9.19
$10.75
$9.55
$9.47
10.99
1.45
1796349
975644.9
60284907.04
Chart
TendieTensor AI Analysis
Company
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
Fundamentals
75
-3.900000
4.791870
100
BBG00YB1C8M5
BBG00YB1C8N4
54.00M
72.99M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own LXEO. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.